Coexisting Hepatocellular Carcinoma and Well-Differentiated Pancreatic Neuroendocrine Tumor in a Liver Transplant Candidate: Case Report

Introduction: Hepatocellular carcinoma (HCC) frequently arises in cirrhotic livers and is a leading indication for liver transplantation (LT). The synchronous occurrence of HCC and pancreatic neuroendocrine tumor (pNET) in a patient undergoing evaluation for LT is rare and poses diagnostic and therapeutic challenges. Case Presentation: We report a 49-year-old man with cirrhosis due to hereditary hemochromatosis (HFE c.187C>G [p.His63Asp]; external laboratory, incomplete report) and multifocal HCC within Milan criteria (BCLC A, ECOG 0), listed for transplantation with a MELD-Na of 15 and exception score of 22. During a donor call-up evaluation, an abdominal MRI revealed LI-RADS 4 and 5 hepatic lesions, and an 18 mm mass near the pancreatic head, initially interpreted as a mesenteric lymph node. A Ga-68 DOTANOC PET/CT scan demonstrated intense somatostatin receptor expression in the mesenteric lesion (Krenning 4) and moderate uptake in segment 8 of the liver (Krenning 3). Laparoscopic enucleation confirmed a non-functional well-differentiated G2 pNET (Ki-67 12%) arising from the anterior surface of the pancreatic head, without lymphovascular or perineural invasion. A CT-guided liver biopsy of the segment 8 lesion revealed moderately differentiated HCC (grade 2) establishing two synchronous primary tumors. The hepatic lesions were treated with stereotactic body radiotherapy (SBRT) as bridge therapy before liver transplant (5000 cGy in 5 fractions). Somatostatin analog therapy was not initiated after resection, given complete resection and absence of residual disease on imaging. Approximately five months post-resection, Ga-68 DOTANOC PET/CT and MRI showed stable disease with decreased lesion size, and the patient was reactivated on the waitlist. He underwent liver transplantation on 30 August 2025; however, his postoperative course was complicated by hemorrhagic shock, Enterococcus faecium bacteremia, a biloma with bile leak, and cryptococcal meningitis, ultimately leading to fatal complications. Conclusion: Synchronous occurrence of HCC and pNET in a cirrhotic patient is rare but clinically significant. Histopathologic confirmation was essential to distinguish synchronous primary tumors from metastatic disease and guide transplant eligibility. A multidisciplinary approach incorporating cross-sectional imaging, functional PET/CT, biopsy, and curative-intent treatment of a resectable extrahepatic primary before transplantation is critical for accurate diagnosis and management in complex transplant oncology cases.

Authors

Publication Details

Journal
Case Reports in Oncology
Published
2026-11-21
DOI
https://doi.org/10.1159/cro/abzag104
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Coexisting Hepatocellular Carcinoma and Well-Differentiated Pancreatic Neuroendocrine Tumor in a Liver Transplant Candidate: Case Report

Mónica Tapias, Santiago Walker, Gloria Vecino Vásquez, Deyanira Gonzalez et al.
Case Reports in Oncology
Hepatocellular Carcinoma Treatment and Prognosis
article

Coexisting Hepatocellular Carcinoma and Well-Differentiated Pancreatic Neuroendocrine Tumor in a Liver Transplant Candidate: Case Report

Mónica Tapias, Santiago Walker, Gloria Vecino Vásquez, Deyanira Gonzalez, Fernando Ayala, Alonso Vera Torres, Julian Rojas, Diana Carolina Sotelo, Johanna Alvarez Figueroa, Katherine Marrugo, Francisco Perez, Andres Florez
article en

Abstract

Introduction: Hepatocellular carcinoma (HCC) frequently arises in cirrhotic livers and is a leading indication for liver transplantation (LT). The synchronous occurrence of HCC and pancreatic neuroendocrine tumor (pNET) in a patient undergoing evaluation for LT is rare and poses diagnostic and therapeutic challenges. Case Presentation: We report a 49-year-old man with cirrhosis due to hereditary hemochromatosis (HFE c.187C>G [p.His63Asp]; external laboratory, incomplete report) and multifocal HCC within Milan criteria (BCLC A, ECOG 0), listed for transplantation with a MELD-Na of 15 and exception score of 22. During a donor call-up evaluation, an abdominal MRI revealed LI-RADS 4 and 5 hepatic lesions, and an 18 mm mass near the pancreatic head, initially interpreted as a mesenteric lymph node. A Ga-68 DOTANOC PET/CT scan demonstrated intense somatostatin receptor expression in the mesenteric lesion (Krenning 4) and moderate uptake in segment 8 of the liver (Krenning 3). Laparoscopic enucleation confirmed a non-functional well-differentiated G2 pNET (Ki-67 12%) arising from the anterior surface of the pancreatic head, without lymphovascular or perineural invasion. A CT-guided liver biopsy of the segment 8 lesion revealed moderately differentiated HCC (grade 2) establishing two synchronous primary tumors. The hepatic lesions were treated with stereotactic body radiotherapy (SBRT) as bridge therapy before liver transplant (5000 cGy in 5 fractions). Somatostatin analog therapy was not initiated after resection, given complete resection and absence of residual disease on imaging. Approximately five months post-resection, Ga-68 DOTANOC PET/CT and MRI showed stable disease with decreased lesion size, and the patient was reactivated on the waitlist. He underwent liver transplantation on 30 August 2025; however, his postoperative course was complicated by hemorrhagic shock, Enterococcus faecium bacteremia, a biloma with bile leak, and cryptococcal meningitis, ultimately leading to fatal complications. Conclusion: Synchronous occurrence of HCC and pNET in a cirrhotic patient is rare but clinically significant. Histopathologic confirmation was essential to distinguish synchronous primary tumors from metastatic disease and guide transplant eligibility. A multidisciplinary approach incorporating cross-sectional imaging, functional PET/CT, biopsy, and curative-intent treatment of a resectable extrahepatic primary before transplantation is critical for accurate diagnosis and management in complex transplant oncology cases.

Case Reports in Oncology
Hepatocellular Carcinoma Treatment and Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon